Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of moxifloxacin hydrochloride

A technology of moxifloxacin hydrochloride and hydrochloric acid, which is applied in the field of preparation of moxifloxacin hydrochloride, can solve the problems of many impurities, large loss of moxifloxacin hydrochloride, and insufficient product quality

Active Publication Date: 2022-04-26
广西两面针亿康药业股份有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in the currently disclosed preparation and synthesis methods, the obtained moxifloxacin hydrochloride has relatively large loss, low yield and liquid phase purity, many impurities, and the product quality is not good enough, especially when moxifloxacin hydrochloride is produced industrially.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of moxifloxacin hydrochloride
  • A kind of preparation method of moxifloxacin hydrochloride
  • A kind of preparation method of moxifloxacin hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] A preparation method of moxifloxacin hydrochloride, using ethyl 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylate Condensate with (S,S)-2,8-diazabicyclo[4,3,0]nonane as the parent ring, then add 6N hydrochloric acid twice after the alkali hydrolysis is completed, and continuously crystallize two The second time, the crystalline product obtained in the second time was recrystallized once with ethanol to obtain moxifloxacin hydrochloride with high content and high quality. Specific steps are as follows:

[0036] (1) Add the weighed boric acid and zinc chloride into a 50L reaction tank, pump acetic anhydride into the reaction tank, heat with jacket steam under stirring, raise the temperature to 110°C-120°C, and keep the temperature for 2 hours; the heat preservation is over , lower the temperature to below 100°C, pump glacial acetic acid into the reaction tank, raise the temperature to 110°C-120°C, and keep it warm for 1 hour.

[0037] (2) Open ...

Embodiment 2

[0050] A preparation method of moxifloxacin hydrochloride, using ethyl 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylate Condensate with (S,S)-2,8-diazabicyclo[4,3,0]nonane as the parent ring, then add 6N hydrochloric acid twice after the alkali hydrolysis is completed, and continuously crystallize two The second time, the crystalline product obtained in the second time was recrystallized once with ethanol to obtain moxifloxacin hydrochloride with high content and high quality. Specific steps are as follows:

[0051] (1) Add the weighed boric acid and zinc chloride into a 50L reaction tank, pump acetic anhydride into the reaction tank, heat with jacket steam under stirring, raise the temperature to 110°C-120°C, and keep the temperature for 2 hours; the heat preservation is over , lower the temperature to below 100°C, pump glacial acetic acid into the reaction tank, raise the temperature to 110°C-120°C, and keep it warm for 1 hour.

[0052] (2) Ope...

Embodiment 3

[0065] A preparation method of moxifloxacin hydrochloride, using ethyl 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylate Condensate with (S,S)-2,8-diazabicyclo[4,3,0]nonane as the parent ring, then add 6N hydrochloric acid twice after the alkali hydrolysis is completed, and continuously crystallize two The second time, the crystalline product obtained in the second time was recrystallized once with ethanol to obtain moxifloxacin hydrochloride with high content and high quality. Specific steps are as follows:

[0066] (1) Add the weighed boric acid and zinc chloride into a 50L reaction tank, pump acetic anhydride into the reaction tank, heat with jacket steam under stirring, raise the temperature to 110°C-120°C, and keep the temperature for 2 hours; the heat preservation is over , lower the temperature to below 100°C, pump glacial acetic acid into the reaction tank, raise the temperature to 110°C-120°C, and keep it warm for 1 hour.

[0067] (2) Ope...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of moxifloxacin hydrochloride, which uses 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3- Ethyl quinolinecarboxylate is the parent ring, condensed with (S,S)-2,8-diazabicyclo[4,3,0]nonane as the side chain, and added in two times after alkali hydrolysis 6N hydrochloric acid, continuous crystallization twice, the crystallized product obtained in the second time was recrystallized once with ethanol to obtain moxifloxacin hydrochloride with high content and high quality. The method of the present invention is used to prepare moxifloxacin hydrochloride, which reduces product loss caused by repeated crystallization, reduces labor intensity, reduces energy consumption, improves product stability, and greatly improves product quality at the same time, and is suitable for large-scale industrial production. , the prepared moxifloxacin hydrochloride is calculated as anhydrous, containing C 21 h 25 ClFN 3 o 4 It is 99.6%~102.0%, and the total impurity content is low.

Description

technical field [0001] The invention relates to the technical field of medicinal chemistry, in particular to a preparation method of moxifloxacin hydrochloride. Background technique [0002] Moxifloxacin HydrocHloride (Moxifloxacin HydrocHloride) is an ultra-broad-spectrum fluoroquinolone antibacterial drug launched by Bayer Company in Germany. Moxifloxacin Hydrochloride was first listed in Germany in 1999 and is used to treat upper and lower respiratory tract infections (such as: Acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, and skin and soft tissue infections) adults, has strong antibacterial activity, broad antibacterial spectrum, is not easy to produce drug resistance and is effective against common drug-resistant bacteria, long half-life, and less adverse reactions And many other advantages, with the clinical application, its curative effect is more and more affirmed. There are many synthetic methods about moxifloxacin hydroch...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04
CPCC07D471/04
Inventor 莫善军何政剑何群覃旭韦岳正熊春媚韦泰新范桂红黄敏聪赖一竹陆琪锋黄敬洲
Owner 广西两面针亿康药业股份有限公司